Cardiology Update India 2020
Invitation
Dear collegues
It is a pleasure to announce the 2nd Indo-European Cardiology Update to be held on September 19th - 20th, 2020. Based on the tremendous success and wide acclaim for the Cardiology Update 2019 in Mumbai, the organizers have assembled a truly spectacular scientific program for this year. The joint Indo-European collaboration in the field of cardiology from prevention to management of coronary disease and heart failure is an important avenue to decrease the chronic disease burden in India.
The proposed scientific agenda includes the latest trends in hypertension, Lipid disorders and diabetes based on evidence and the most recent guidelines which are of paramount importance to the physicians in clinical practice. The course will further include state-of-art presentations by eminent Indian and European faculty known for their clinical expertise in the most common cardiac conditions.
We are confident that the Indo-European Cardiology Update 2020 will be yet another milestone in professional education and in the annals of preventive cardiology. The attendees will gain additional clinical tools in the early identification of cardiovascular risk factors and in the management of cardiovascular disease in the community.
Best wishes and kind regards,
Thomas F. Lüscher and C. Venkata S. Ram
Programme
Day - 1 Saturday, September 19th, 2020
Times listed in India time
Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm | ||
IST | ||
5:00 pm | Welcome, Introduction | C.Venkata S.Ram, Hyderabad, India |
5:10 pm | Greetings from Zurich Heart House | Thomas F. Lüscher, London & Zurich |
Session 1: Prevention Chairs: Ulrich Laufs, Leipzig, Germany & P.P. Mohanan, Thissur, India |
||
5:20 pm | A personalized approach towards prevention | Thomas F. Lüscher, London & Zurich |
5:40 pm | Hypertension 2020: Salient Features | C. Venkata S. Ram, Hyderabad, India |
6:00 pm | Dyslipidaemia: Treatment targets and novel strategies (new ESC Guidelines) |
Ulrich Laufs, Leipzig, Germany |
6:20 pm | Optimal pharmacotherapy to achieve lipid target levels in clinical practice |
J.P.S. Sawhney, New Delhi, India |
6:40 pm | Panel discussion, Q and A | Audience Participation |
Session 2: Cardiovascular Disease: An Overview Chairs: Bernard Gersh, Rochester, USA & C.K. Ponde, Mumbai, India |
||
7:15pm | Management of chronic coronary syndromes after the ISCHEMIA trial:Do we need to change the current ESC and US Guidelines? |
Bernard Gersh, Rochester, USA |
7:35pm | Dual antiplatelet therapy: Scientific evidence and a practical guide | Ajit Mullasari, Chennai, India |
7:55pm | What is the current status and evidence for aspirin usage in the prevention of vascular disease |
P.P. Mohanan, Thrissur, India |
8:15pm | Panel discussion, Q and A | Audience Participation |
Session End Time: London 3:45 pm, Zurich 4:45 pm & India 8:15 pm |
Day - 2 Sunday, September 20th, 2020
Times listed in India time
Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm | ||
Session 3: Cardiovascular Disease: Hot Topics Chairs: Jamshed Dalal, Mumbai, India & Lars Sondergaard, Copenhagen, Denmark |
||
5:00pm | Important and interesting cardiac arrhythmias in clinical practice: A tutorial |
Calambur Narasimhan, Hyderabad, India |
5:20pm | Management of Aortic valve disease in 2020 | Lars Soendergaard, Copenhagen, Denmark |
5:40pm | Non-invasive technique to detect coronary artery disease | Rishi Sethi, Lucknow, India |
6:00pm | Panel discussion, Q and A | Audience Participation |
Session 4: Cardio-Metabolic Disorders, Heart Failure Chairs: Yash Lokhandawala, Mumbai, India & Martin Cowie, London, UK |
||
6:30pm | Importance of additional cardiovascular risk reduction in diabetes: The role of statins |
Nagaraj Desai, Bangalore, India |
6:50pm | Heart failure and diabetes: Mechanisms and new treatment options(ESC Guidelines) |
Ulrich Laufs, Leipzig, Germany |
7:10pm | Adjunctive and complementary therapeutic approaches to decrease the overall cardiovascular disease risk in the community |
Rajeev Agarwala, Meerut, India |
7:30pm | Rationale behind combination lipid lowering therapy in high risk patients | Jamshed Dalal, Mumbai, India |
7:50pm | Panel discussion, Q and A | Audience Participation |
8:20pm | Concluding remarks and way forward | Thomas F. Lüscher, London & Zurich C.Venkata S.Ram, Hyderabad, India |
Session End Time: London 3:50 pm, Zurich 4:50 pm & India 8:20 pm |